Pyxis Oncology (PYXS) Receivables - Net (2024 - 2025)

Pyxis Oncology (PYXS) reported Receivables - Net of $3.0 million for Q2 2025, down 62.5% quarter-over-quarter from $8.0 million in Q1 2024.

Pyxis Oncology (PYXS) Receivables - Net (2024 - 2025) Analysis & Trends

Pyxis Oncology (PYXS) has 2 years of Receivables - Net data on file, last reported at $3.0 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Pyxis Oncology	125.84 Mn	108.95 Mn	8.65 Mn

Download Data